BREAKING: The FDA just reversed their 2023 peptide ban. 12 peptides pulled from the Category 2 restricted list: 1. BPC 157 2. Thymosin beta 4 fragment (TB 500) 3. Epitalon 4. GHK Cu 5. MOTS C 6. HIMS: Regulatory Arbitrage and the Future of Personalized Medicine Liraglutide Dosage Chart Olympia Pharmaceuticals When will the FDA reclassify BPC 157 to Category 1 Octagon AI FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of